Although myocardial infarction (MI) and atherothrombotic ischemic stroke are thought to be caused by rupture of vulnerable atherosclerotic plaques,
1 they are recognized to be complex disorders that likely result from multifaceted interactions between an individual's genetic makeup and environmental factors.
2,3 Increasing evidence supports a central role for inflammation in the cascade of events that results in plaque fissuring.
4,5 Lesion macrophages synthesize matrix metalloproteinases (MMPs); in particular, 72-kDa (MMP-2) and 92-kDa (MMP-9) gelatinase, proteolytic enzymes capable of degrading plaque constituents.
6 We recently reported that enhanced MMP-2 and MMP-9 production by macrophages in vulnerable plaques is due to enhancement in prostaglandin E
2 (PGE
2) synthesis as a result of the induction of COX-2.
6-9